Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
A 2024 retrospective cohort analysis published in Diabetes, Obesity and Metabolism (N=312 patients who switched from semaglutide to tirzepatide at a single academic center) found that switchers lost an additional mean of 6.3% of body weight over 6 months after the switch, with 68% reporting either stable or improved GI tolerability [12]
PMID: 134 LiLXiongQZhaoJLinXHeSWuNet al
1997;37(3 Pt 1):491-493
If you frequently struggle with adherence, discuss this openly with your GP or diabetes specialist nurse, as they may suggest strategies tailored to your lifestyle or consider whether alternative treatment regimens might be more suitable for your circumstances
